Q3 2024 Earnings Forecast for Apogee Therapeutics, Inc. Issued By Wedbush (NASDAQ:APGE)
Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) – Wedbush reduced their Q3 2024 earnings per share estimates for Apogee Therapeutics in a note issued to investors on Monday, August 12th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.70) for the quarter, down from their prior estimate of […]
More Stories
Is Crew Girl Renewed for Season 2? Release Date, Cast, and Production Details
Are you also a fan of Canadian drama? Miku and Kyle’s duo is returning with Crew Girl Season 2. It...
The Four Seasons Season 3: Release Date, Cast, Episodes, and More
Looking for an upcoming American romantic-comedy drama series? Good news! The popular friendship-based series is coming back. The Four Seasons...
Take Charge of My Heart: Release Date, Trailer, Plot, and More
Are you also hunting for the next Korean romantic-comedy drama? Then your search ends here. Take Charge of My Heart...
Minerva Academy: Release Date, Plot, Cast, Trailer, and More
Netflix’s latest Italian drama Minerva Academy is currently streaming online on the popular streaming network Netflix. Its original title is...
8 Best Commercial Skylight Companies for US Projects (2026)
Getting commercial daylighting wrong is expensive in a way residential work rarely is. A leaking curb on a house is...
Is Sweet Magnolias Season 6 Renewed? Latest News and Review
Netflix’s romantic drama Sweet Magnolias has finally come to an end. In September 2026, Deadline officially announced that one of...